Progress in the Detection of Cerebrospinal Fluid by Raman Spectroscopy

被引：2
|
作者：
Song, Yali [1 ]
Bian, Handan [1 ]
Zeng, Tingting [1 ,3 ]
Lin, Ting [2 ]
Liu, Yuxin [1 ]
Deng, Shanying [1 ]
Liao, Juan [1 ]
Mao, Zhigang [1 ]
Chen, Si [1 ]
机构：
[1] Sichuan Univ, West China Hosp, Dept Lab Med, Chengdu, Sichuan, Peoples R China
[2] Sichuan Univ, West China Hosp, Dept Hematol, Res Lab Hematol, Chengdu, Sichuan, Peoples R China
[3] Sichuan Univ, West China Hosp, Dept Lab Med, 37 Guoxue Xiang, Chengdu, Sichuan, Peoples R China
来源：
CURRENT NANOSCIENCE | 2023年 / 19卷 / 03期
关键词：
Raman spectroscopy; cerebrospinal fluid; nanostructure; Alzheimer's disease; dopamine; neurodegeneration; ALZHEIMERS-DISEASE; PARKINSONS-DISEASE; SELECTIVE SEPARATION; CLINICAL-FEATURES; DIAGNOSTIC-TOOL; SERS DETECTION; MENINGITIS; BIOMARKERS; DOPAMINE; PROTEIN;
D O I：
10.2174/1573413718666220803141856
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
As a precious sterile body fluid, cerebrospinal fluid (CSF) examination plays an important role in the diagnosis of many clinical diseases. Early diagnosis can significantly improve these diseases' survival rate. Raman spectroscopy is a scattering spectrum that has been used for the research and analysis of molecular structures. It has been widely used in many fields, such as protein detection, tumor genes, microbiological pathogen compound materials, and food and medical monitoring, with high sensitivity and specificity. In this review, we briefly introduce the mechanism of Raman spectroscopy and summarize its progress in detecting cerebrospinal fluid, mainly focusing on the application of neurodegenerative diseases by Raman spectroscopy. Meanwhile, we also prospect the development of Raman spectroscopy in the detection of CSF and other fluids.
引用
收藏
页码：338 / 349
页数：12
相关论文
共 50 条
  • [31] The influence of cerebrospinal fluid turnover on age-related changes in cerebrospinal fluid protein concentrations
    Chen, Carl P. C.
    Chen, Ruo Li
    Preston, Jane E.
    NEUROSCIENCE LETTERS, 2010, 476 (03) : 138 - 141
  • [32] Preliminary study of hsa-miR-626 change in the cerebrospinal fluid of Parkinson's disease patients
    Qin, Li-xia
    Tan, Jie-qiong
    Zhang, Hai-nan
    Tang, Jian-guang
    Jiang, Bo
    Shen, Xiang-min
    Tang, Bei-sha
    Wang, Chun-yu
    JOURNAL OF CLINICAL NEUROSCIENCE, 2019, 70 : 198 - 201
  • [33] Upcoming candidate cerebrospinal fluid biomarkers of Alzheimer's disease
    Fagan, Anne M.
    Perrin, Richard J.
    BIOMARKERS IN MEDICINE, 2012, 6 (04) : 455 - 476
  • [34] Longitudinal Measurements of Cerebrospinal Fluid Biomarkers in Parkinson's Disease
    Hall, Sara
    Surova, Yulia
    Ohrfelt, Annika
    Blennow, Kaj
    Zetterberg, Henrik
    Hansson, Oskar
    MOVEMENT DISORDERS, 2016, 31 (06) : 898 - 905
  • [35] Cerebrospinal fluid and plasma clusterin levels in Parkinson's disease
    van Dijk, Karin D.
    Jongbloed, Wesley
    Heijst, Johannes A.
    Teunissen, Charlotte E.
    Groenewegen, Henk J.
    Berendse, Henk W.
    van de Berg, Wilma D. J.
    Veerhuis, Robert
    PARKINSONISM & RELATED DISORDERS, 2013, 19 (12) : 1079 - 1083
  • [36] Cerebrospinal Fluid Sphingomyelins in Alzheimer's Disease, Neurodegeneration, and Neuroinflammation
    Morrow, Autumn
    Panyard, Daniel J.
    Deming, Yuetiva K.
    Jonaitis, Erin
    Dong, Ruocheng
    Vasiljevic, Eva
    Betthauser, Tobey J.
    Kollmorgen, Gwendlyn
    Suridjan, Ivonne
    Bayfield, Anna
    Van Hulle, Carol A.
    Zetterberg, Henrik
    Blennow, Kaj
    Carlsson, Cynthia M.
    Asthana, Sanjay
    Johnson, Sterling C.
    Engelman, Corinne D.
    JOURNAL OF ALZHEIMERS DISEASE, 2022, 90 (02) : 667 - 680
  • [37] Diagnostic and prognostic value of human prion detection in cerebrospinal fluid
    Foutz, Aaron
    Appleby, Brian S.
    Hamlin, Clive
    Liu, Xiaoqin
    Yang, Sheng
    Cohen, Yvonne
    Chen, Wei
    Blevins, Janis
    Fausett, Cameron
    Wang, Han
    Gambetti, Pierluigi
    Zhang, Shulin
    Hughson, Andrew
    Tatsuoka, Curtis
    Schonberger, Lawrence B.
    Cohen, Mark L.
    Caughey, Byron
    Safar, Jiri G.
    ANNALS OF NEUROLOGY, 2017, 81 (01) : 79 - 92
  • [38] Two-level diagnostic classification using cerebrospinal fluid YKL-40 in Alzheimer's disease
    Baldacci, Filippo
    Toschi, Nicola
    Lista, Simone
    Zetterberg, Henrik
    Blennow, Kaj
    Kilimann, Ingo
    Teipel, Stefan
    Cavedo, Enrica
    dos Santos, Antonio Melo
    Epelbaum, Stephane
    Lamari, Foudil
    Dubois, Bruno
    Floris, Roberto
    Garaci, Francesco
    Bonuccelli, Ubaldo
    Hampel, Harald
    ALZHEIMERS & DEMENTIA, 2017, 13 (09) : 993 - 1003
  • [39] Cerebrospinal fluid α-synuclein contributes to the differential diagnosis of Alzheimer's disease
    Shi, Min
    Tang, Lu
    Toledo, Jon B.
    Ginghina, Carmen
    Wang, Hua
    Aro, Patrick
    Jensen, Poul H.
    Weintraub, Daniel
    Chen-Plotkin, Alice S.
    Irwin, David J.
    Grossman, Murray
    McCluskey, Leo
    Elman, Lauren B.
    Wolk, David A.
    Lee, Edward B.
    Shaw, Leslie M.
    Trojanowski, John Q.
    Zhang, Jing
    ALZHEIMERS & DEMENTIA, 2018, 14 (08) : 1052 - 1062
  • [40] Cerebrospinal fluid β-amyloid and dynabridging in Alzheimer's disease drug development
    Ereshefsky, Larry
    Jhee, Stanford
    Yen, Mark
    Moran, Samira
    Pretorius, Sybrand
    Adams, James
    BIOMARKERS IN MEDICINE, 2009, 3 (06) : 711 - 721
12345